Weight loss induced by semaglutide can reduce hepatic steatosis (fat accumulation in the liver), decrease liver inflammation, and improve liver enzyme levels in individuals with obesity-related liver disease
Polyphenols synergistic drugs to ameliorate non-alcoholic fatty liver disease via signal pathway and gut microbiota: A review
Microdosing GLP-1 results: 18 pounds lost in 11 weeks Kelsey lost 18 pounds after eleven weeks on the Noom Microdose GLP-1 Rx Program
Healthcare providers should assess for conditions that increase appetite, including uncontrolled diabetes (check HbA1c), thyroid disorders (TSH, free T4), and psychiatric conditions
Additionally, constipation can be an issue, affecting roughly 30% of people during early GLP-1 treatment, largely due to reduced fluid and fiber intake
This comprehensive testing protocol gives researchers confidence in their materials